Alpha Sense BI

FEBRUARY 8, 2023

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices — as well as their intentions to scale their digital health solutions — to the masses in hopes of securing capital.

Biotech 96

Biotech Research Innovation Capital 96

Netbasequid

FEBRUARY 22, 2021

And they used NetBase Quid to inform their research. We’ll provide a high-level summary here, and some practical applications of frameworks they’ve used that could apply to powering your own research on any number of topics. Investment intelligence to inform deep tech understanding. From here, the biotech world is your oyster.

Biotech 98

Biotech Innovation Intellectual Property Market Research 98

BIS Research

MARCH 19, 2019

This approach enables providers to gather data about the molecular mechanisms of an individual being tested, which further enables researchers to develop targeted therapies and preventive strategies. The precision therapeutics is segmented into clinical trials, cell therapy, drug discovery and research, and gene therapy.

Globalization 64

Globalization Biotech Marketing Marketing 64

Sedulo

MARCH 15, 2023

Our analysis of global data gathered from multiple trial registries provided a compelling snapshot of the recent IO clinical landscape and prompted several unanswered questions regarding future evolution and the impact on manufacturers competing in the space. Assess and benchmark enrollment timing. Monitor key activity within the landscape.

Biotech 52

Biotech Competitive Landscape Pharmaceutical Benchmarking 52

Alpha Sense BI

JANUARY 25, 2023

Over the last three years, the COVID-19 pandemic brought new energy to manufacturing vaccines for a myriad of global diseases and health conditions. Using the AlphaSense platform, we dug deep into new drug research and development areas that will likely shape the 2023 vaccine market. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Alpha Sense BI

APRIL 29, 2024

The Transformative Effect of Generative AI By 2025, it is estimated that more than 75% of venture capital (VC) and early-stage investor executive reviews will be informed using artificial intelligence (AI) and data analytics. There is no doubt that generative AI has emerged as a powerful tool in the investment space.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

APRIL 19, 2024

On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. 2023 was all about learning the use cases of genAI, as companies raced to introduce their own genAI offerings and capabilities into a fiercely competitive market (i.e.

Technology 69

Technology Technology Retail Biotech 69